Amedisys Inc (STU:ADY)
€ 86.5 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript

May 18, 2021 / 05:20PM GMT
Release Date Price: €202 (-0.98%)
Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst

Good afternoon. This is Frank Morgan. And we'll continue our afternoon series of fireside chats with the management team from Amedisys. We have Paul Kusserow, CEO; Scott Ginn, CFO; Chris Gerard; and Nick Muscato. Welcome, gentlemen.

Paul Berthold Kusserow
Amedisys, Inc. - Chairman & CEO

Hi, Frank. How are you doing?

Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst

We're all good. All is good. Hopefully, by next year, we'll do this thing live, and the virtual world will be a thing of the past.

Questions & Answers

Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst

But in the meantime, I guess we should go ahead and get started. Maybe, at a high level, could we first spend a couple of minutes just assessing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot